Biopharm News - BioPharm International


Biopharm News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

Myriad Genetics Expands Companion Diagnostic Pact with AstraZeneca

September 9, 2013

Myriad Genetics and AstraZeneca expand their companion diagnostic pact for AztraZeneca?s investigational drug candidate olaparib.

Zealand Announces Collaboration with Eli Lilly

September 5, 2013

Zealand will join efforts with Eli Lilly to design and develop therapeutic peptides for Type 2 diabetes and obesity.

CordenPharma to Acquire Peptisyntha SA from Solvay

September 5, 2013

CordenPharma will acquire Peptisyntha SA, based in Belgium.

Sanofi Pasteur Selects Freeslate to Improve Formulation Development

August 28, 2013

Sanofi Pasteur has purchased Freeslate?s Biologics Formulation System for accelerating research in vaccine and protein formulation development.

Amarin Targets Novasep as Fourth Supplier of Vascepa API

August 28, 2013

Amarin released the submission of an sNDA to FDA seeking approval for Novasep Group.

Shire, and Santaris Extend Alliance to Develop LNA-drugs

August 26, 2013

Santaris Pharma and Shire have extended their partnership in the rare genetic disease space.

Vical Restructures and Reduces Staff

August 26, 2013

Vical's restructuring will leave the company with approximately 74 employees.

Amgen and Servier Complete Product Collaboration Transaction

August 14, 2013

Amgen, Servier collaborate ivabraline and other cardiovascular products.

Lonza Licenses Gene Expression Technology to Sorrento

August 8, 2013

The companies sign a nonexclusive research license agreement, giving Sorrento's access to Lonza's GS Xceed Gene Expression System.



Click here